chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Diarrhoea, Headache, Inflammation
Clinical narrative: General body pain; severe inflammation every where; bled from the needle the second; headache; Pain in hip; General body pain; Diarrhea; chills; This spontaneous case was reported by a consumer and describes the occurrence of INJURY ASSOCIATED WITH DEVICE (bled from the needle the second), the first episode of PAIN (General body pain), the second episode of PAIN (General body pain), INFLAMMATION (severe inflammation every where) and DIARRHOEA (Diarrhea) in a 53-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 28-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, the patient experienced the first episode of PAIN (General body pain), DIARRHOEA (Diarrhea), CHILLS (chills) and ARTHRALGIA (Pain in hip). On 05-Mar-2021, the patient experienced HEADACHE (headache). On 28-Mar-2021, the patient experienced INJURY ASSOCIATED WITH DEVICE (bled from the needle the second). On 29-Mar-2021, the patient experienced INFLAMMATION (severe inflammation every where). On an unknown date, the patient experienced the second episode of PAIN (General body pain). On 22-Mar-2021, DIARRHOEA (Diarrhea), CHILLS (chills), HEADACHE (headache) and ARTHRALGIA (Pain in hip) had resolved. At the time of the report, INJURY ASSOCIATED WITH DEVICE (bled from the needle the second) and INFLAMMATION (severe inflammation every where) outcome was unknown and last episode of PAIN (General body pain) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This case was linked to MOD-2021-064585 (Patient Link).
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Injury associated with device, Pain
Clinical narrative: General body pain; severe inflammation every where; bled from the needle the second; headache; Pain in hip; General body pain; Diarrhea; chills; This spontaneous case was reported by a consumer and describes the occurrence of INJURY ASSOCIATED WITH DEVICE (bled from the needle the second), the first episode of PAIN (General body pain), the second episode of PAIN (General body pain), INFLAMMATION (severe inflammation every where) and DIARRHOEA (Diarrhea) in a 53-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 28-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, the patient experienced the first episode of PAIN (General body pain), DIARRHOEA (Diarrhea), CHILLS (chills) and ARTHRALGIA (Pain in hip). On 05-Mar-2021, the patient experienced HEADACHE (headache). On 28-Mar-2021, the patient experienced INJURY ASSOCIATED WITH DEVICE (bled from the needle the second). On 29-Mar-2021, the patient experienced INFLAMMATION (severe inflammation every where). On an unknown date, the patient experienced the second episode of PAIN (General body pain). On 22-Mar-2021, DIARRHOEA (Diarrhea), CHILLS (chills), HEADACHE (headache) and ARTHRALGIA (Pain in hip) had resolved. At the time of the report, INJURY ASSOCIATED WITH DEVICE (bled from the needle the second) and INFLAMMATION (severe inflammation every where) outcome was unknown and last episode of PAIN (General body pain) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This case was linked to MOD-2021-064585 (Patient Link).
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Somnolence
Clinical narrative: Got sleepy; This spontaneous case was reported by a consumer and describes the occurrence of   in an 84-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided. The reporter stated that her husband got sleepy after his Moderna vaccine. Treatment for the event was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 15-Jun-2021: received and updated the Event duration and outcome
Sex: F
Vaccine: COVID19
Symptoms: Chills, Diarrhoea, Hot flush, Migraine, Paranasal sinus discomfort
Clinical narrative: Severe diarrhea; Hot flashes; Sinus pressure; Migraines; Chills; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Severe diarrhea), HOT FLUSH (Hot flashes), PARANASAL SINUS DISCOMFORT (Sinus pressure), MIGRAINE (Migraines) and CHILLS (Chills) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In March 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In March 2021, the patient experienced DIARRHOEA (Severe diarrhea), HOT FLUSH (Hot flashes), PARANASAL SINUS DISCOMFORT (Sinus pressure), MIGRAINE (Migraines) and CHILLS (Chills). At the time of the report, DIARRHOEA (Severe diarrhea), HOT FLUSH (Hot flashes), PARANASAL SINUS DISCOMFORT (Sinus pressure), MIGRAINE (Migraines) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication provided. No treatment information mentioned.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Pyrexia, Rash, Vaccination site reaction
Clinical narrative: Covid Arm; Rash went all the way around her arm; Fever 100.1F; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (Covid Arm), PYREXIA (Fever 100.1F) and RASH (Rash went all the way around her arm) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 01-Mar-2021, the patient experienced PYREXIA (Fever 100.1F). On 12-Mar-2021, the patient experienced VACCINATION SITE REACTION (Covid Arm) and RASH (Rash went all the way around her arm). The patient was treated with PARACETAMOL (TYLENOL) for Fever, at a dose of 1 dosage form. At the time of the report, VACCINATION SITE REACTION (Covid Arm), PYREXIA (Fever 100.1F) and RASH (Rash went all the way around her arm) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 12-Mar-2021, Body temperature: 100.8 (High) 100.8 DEGREE FAHRENHEIT.         Action taken with mRNA-1273 in response to the drug was not applicable. No concomitant medication information was provided.
Sex: U
Vaccine: COVID19
Symptoms: Interchange of vaccine products
Clinical narrative: Received Pfizer as first dose and Moderna for second dose; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of INTERCHANGE OF VACCINE PRODUCTS (Received Pfizer as first dose and Moderna for second dose) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced INTERCHANGE OF VACCINE PRODUCTS (Received Pfizer as first dose and Moderna for second dose). At the time of the report, INTERCHANGE OF VACCINE PRODUCTS (Received Pfizer as first dose and Moderna for second dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter. Treatment information was not provided.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Bladder pain, Bladder spasm, Blood urine
Clinical narrative: Bladder pain; Bladder spasm; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of BLADDER PAIN (Bladder pain) and BLADDER SPASM (Bladder spasm) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination.     Concomitant products included BOTULINUM TOXIN TYPE A (BOTOX) and OXYCODONE HYDROCHLORIDE, OXYCODONE TEREPHTHALATE, PARACETAMOL (PERCOCET [OXYCODONE HYDROCHLORIDE;OXYCODONE TEREPHTHALATE;PARACETAMOL]) for an unknown indication.    On 28-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Mar-2021, the patient experienced BLADDER PAIN (Bladder pain) and BLADDER SPASM (Bladder spasm). At the time of the report, BLADDER PAIN (Bladder pain) and BLADDER SPASM (Bladder spasm) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 28-Feb-2021, Blood urine: present (abnormal) present.         Treatment informations include Botox and Percocet.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dizziness, Erythema, Eye swelling, Myalgia
Clinical narrative: her throat got hard to swallow and tight; bottom of her left eye swelled and left side of her face swelled; bottom of her left eye swelled and left side of her face swelled; redness was there and on her chest; lightheaded/dizzy; redness on her arm at her injection site; chills; low-grade fevers; body aches; This spontaneous case was reported by a health care professional (subsequently medically confirmed) and describes the occurrence of THROAT TIGHTNESS (her throat got hard to swallow and tight), SWELLING FACE (bottom of her left eye swelled and left side of her face swelled), EYE SWELLING (bottom of her left eye swelled and left side of her face swelled), CHILLS (chills) and PYREXIA (low-grade fevers) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 28-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Mar-2021, the patient experienced CHILLS (chills), PYREXIA (low-grade fevers) and MYALGIA (body aches). On 30-Mar-2021, the patient experienced VACCINATION SITE ERYTHEMA (redness on her arm at her injection site). On 31-Mar-2021, the patient experienced THROAT TIGHTNESS (her throat got hard to swallow and tight), SWELLING FACE (bottom of her left eye swelled and left side of her face swelled), EYE SWELLING (bottom of her left eye swelled and left side of her face swelled), ERYTHEMA (redness was there and on her chest) and DIZZINESS (lightheaded/dizzy). On 01-Apr-2021, THROAT TIGHTNESS (her throat got hard to swallow and tight), SWELLING FACE (bottom of her left eye swelled and left side of her face swelled), EYE SWELLING (bottom of her left eye swelled and left side of her face swelled), CHILLS (chills), PYREXIA (low-grade fevers), MYALGIA (body aches), VACCINATION SITE ERYTHEMA (redness on her arm at her injection site), ERYTHEMA (redness was there and on her chest) and DIZZINESS (lightheaded/dizzy) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   .
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Swelling face, Throat tightness, Vaccination site erythema
Clinical narrative: her throat got hard to swallow and tight; bottom of her left eye swelled and left side of her face swelled; bottom of her left eye swelled and left side of her face swelled; redness was there and on her chest; lightheaded/dizzy; redness on her arm at her injection site; chills; low-grade fevers; body aches; This spontaneous case was reported by a health care professional (subsequently medically confirmed) and describes the occurrence of THROAT TIGHTNESS (her throat got hard to swallow and tight), SWELLING FACE (bottom of her left eye swelled and left side of her face swelled), EYE SWELLING (bottom of her left eye swelled and left side of her face swelled), CHILLS (chills) and PYREXIA (low-grade fevers) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 28-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Mar-2021, the patient experienced CHILLS (chills), PYREXIA (low-grade fevers) and MYALGIA (body aches). On 30-Mar-2021, the patient experienced VACCINATION SITE ERYTHEMA (redness on her arm at her injection site). On 31-Mar-2021, the patient experienced THROAT TIGHTNESS (her throat got hard to swallow and tight), SWELLING FACE (bottom of her left eye swelled and left side of her face swelled), EYE SWELLING (bottom of her left eye swelled and left side of her face swelled), ERYTHEMA (redness was there and on her chest) and DIZZINESS (lightheaded/dizzy). On 01-Apr-2021, THROAT TIGHTNESS (her throat got hard to swallow and tight), SWELLING FACE (bottom of her left eye swelled and left side of her face swelled), EYE SWELLING (bottom of her left eye swelled and left side of her face swelled), CHILLS (chills), PYREXIA (low-grade fevers), MYALGIA (body aches), VACCINATION SITE ERYTHEMA (redness on her arm at her injection site), ERYTHEMA (redness was there and on her chest) and DIZZINESS (lightheaded/dizzy) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   .
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Bone pain
Clinical narrative: bone pain; This spontaneous case was reported by a consumer and describes the occurrence of BONE PAIN (bone pain) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 05-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, the patient experienced BONE PAIN (bone pain). On 06-Mar-2021, BONE PAIN (bone pain) had resolved. Not Provided          Action taken with mRNA-1273 in response to the event was not applicable.  Concomitant medications include Blood pressure medication and Vitamins  No treatment information was provided   This case was linked to US-MODERNATX, INC.-MOD-2021-067331 (E2B Linked Report). This case was linked to MOD-2021-067331 (Patient Link).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-067331:
Age: 86.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Pruritus
Clinical narrative: One week later - intense itching in left shoulder, scratching so much she thought she was going to; waking up out of her sleep with left arm pain, pain was uncomfortable and she was unable to go; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PAIN IN EXTREMITY (waking up out of her sleep with left arm pain, pain was uncomfortable and she was unable to go) and PRURITUS (One week later - intense itching in left shoulder, scratching so much she thought she was going to) in an 86-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension. Concomitant products included PARACETAMOL (TYLENOL) for an unknown indication.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced PAIN IN EXTREMITY (waking up out of her sleep with left arm pain, pain was uncomfortable and she was unable to go). On 16-Mar-2021, the patient experienced PRURITUS (One week later - intense itching in left shoulder, scratching so much she thought she was going to). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) (oral) at a dose of 1 dosage form every four hours. On 10-Mar-2021, PAIN IN EXTREMITY (waking up out of her sleep with left arm pain, pain was uncomfortable and she was unable to go) had resolved. On 17-Mar-2021, PRURITUS (One week later - intense itching in left shoulder, scratching so much she thought she was going to) had resolved. Unknown      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient reported that the second dose of Moderna Covid-19 Vaccine scheduled on 7-Apr-2021. Concomitant medication included blood pressure medication.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Hot flush, Suspected COVID-19, Vaccination complication
Clinical narrative: hot flashes; Still not feeling great; chills; felt like he had COVID again/all the symptoms again; This spontaneous case was reported by a consumer and describes the occurrence of SUSPECTED COVID-19 (felt like he had Covid again/all the symptoms again), HOT FLUSH (hot flashes), VACCINATION COMPLICATION (Still not feeling great) and CHILLS (chills) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029A21A and 028A21A) for COVID-19 vaccination.   The patient's past medical history included COVID-19 in November 2020.   On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 01-Apr-2021, the patient experienced SUSPECTED COVID-19 (felt like he had Covid again/all the symptoms again) and CHILLS (chills). On 05-Apr-2021, the patient experienced HOT FLUSH (hot flashes) and VACCINATION COMPLICATION (Still not feeling great). At the time of the report, SUSPECTED COVID-19 (felt like he had Covid again/all the symptoms again), HOT FLUSH (hot flashes), VACCINATION COMPLICATION (Still not feeling great) and CHILLS (chills) outcome was unknown.         No concomitant and treatment drugs were reported.   This case was linked to MOD-2021-067408 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 23-Jul-2021: Non significant follow-up, contains address of primary reporter.
Sex: U
Vaccine: COVID19
Symptoms: Off label use
Clinical narrative: Second vaccine scheduled 12 Weeks after first vaccine; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of OFF LABEL USE (Second vaccine scheduled 12 Weeks after first vaccine) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced OFF LABEL USE (Second vaccine scheduled 12 Weeks after first vaccine). At the time of the report, OFF LABEL USE (Second vaccine scheduled 12 Weeks after first vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were not reported. No treatment medications were provided.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Insomnia, Malaise, Mobility decreased, Muscle spasms
Clinical narrative: started to feel bad; arm is stiff, heavy, and has lost mobility; unbearable pain in the arm; feels like the bone is broken from the intense pain that she has, it feels like a cramping of the arm; arm is stiff, heavy, and has lost mobility; pain in all the joints of the body; pain and fever have not let her sleep; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (started to feel bad), MUSCULOSKELETAL STIFFNESS (arm is stiff, heavy, and has lost mobility), PAIN IN EXTREMITY (unbearable pain in the arm), MUSCLE SPASMS (feels like the bone is broken from the intense pain that she has, it feels like a cramping of the arm) and MOBILITY DECREASED (arm is stiff, heavy, and has lost mobility) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 02-Apr-2021 at 12:00 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Apr-2021, the patient experienced INSOMNIA (pain and fever have not let her sleep). On 02-Apr-2021 at 7:00 PM, the patient experienced MALAISE (started to feel bad), MUSCULOSKELETAL STIFFNESS (arm is stiff, heavy, and has lost mobility), PAIN IN EXTREMITY (unbearable pain in the arm), MUSCLE SPASMS (feels like the bone is broken from the intense pain that she has, it feels like a cramping of the arm), MOBILITY DECREASED (arm is stiff, heavy, and has lost mobility), PYREXIA (fever) and ARTHRALGIA (pain in all the joints of the body). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 04-Apr-2021, PYREXIA (fever) had resolved. At the time of the report, MALAISE (started to feel bad), MUSCULOSKELETAL STIFFNESS (arm is stiff, heavy, and has lost mobility), PAIN IN EXTREMITY (unbearable pain in the arm), MUSCLE SPASMS (feels like the bone is broken from the intense pain that she has, it feels like a cramping of the arm), MOBILITY DECREASED (arm is stiff, heavy, and has lost mobility), INSOMNIA (pain and fever have not let her sleep) and ARTHRALGIA (pain in all the joints of the body) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were reported for cholesterol, acid reflux and pills for severe arthritis.   Most recent FOLLOW-UP information incorporated above includes: On 16-May-2021: TCR form received on 16-MAY-2021 Contains No new information. On 27-Jun-2021: Follow up received on 27-Jun-2021 and contain non significant information.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Musculoskeletal stiffness, Pain in extremity, Pyrexia
Clinical narrative: started to feel bad; arm is stiff, heavy, and has lost mobility; unbearable pain in the arm; feels like the bone is broken from the intense pain that she has, it feels like a cramping of the arm; arm is stiff, heavy, and has lost mobility; pain in all the joints of the body; pain and fever have not let her sleep; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (started to feel bad), MUSCULOSKELETAL STIFFNESS (arm is stiff, heavy, and has lost mobility), PAIN IN EXTREMITY (unbearable pain in the arm), MUSCLE SPASMS (feels like the bone is broken from the intense pain that she has, it feels like a cramping of the arm) and MOBILITY DECREASED (arm is stiff, heavy, and has lost mobility) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 02-Apr-2021 at 12:00 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Apr-2021, the patient experienced INSOMNIA (pain and fever have not let her sleep). On 02-Apr-2021 at 7:00 PM, the patient experienced MALAISE (started to feel bad), MUSCULOSKELETAL STIFFNESS (arm is stiff, heavy, and has lost mobility), PAIN IN EXTREMITY (unbearable pain in the arm), MUSCLE SPASMS (feels like the bone is broken from the intense pain that she has, it feels like a cramping of the arm), MOBILITY DECREASED (arm is stiff, heavy, and has lost mobility), PYREXIA (fever) and ARTHRALGIA (pain in all the joints of the body). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 04-Apr-2021, PYREXIA (fever) had resolved. At the time of the report, MALAISE (started to feel bad), MUSCULOSKELETAL STIFFNESS (arm is stiff, heavy, and has lost mobility), PAIN IN EXTREMITY (unbearable pain in the arm), MUSCLE SPASMS (feels like the bone is broken from the intense pain that she has, it feels like a cramping of the arm), MOBILITY DECREASED (arm is stiff, heavy, and has lost mobility), INSOMNIA (pain and fever have not let her sleep) and ARTHRALGIA (pain in all the joints of the body) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were reported for cholesterol, acid reflux and pills for severe arthritis.   Most recent FOLLOW-UP information incorporated above includes: On 16-May-2021: TCR form received on 16-MAY-2021 Contains No new information. On 27-Jun-2021: Follow up received on 27-Jun-2021 and contain non significant information.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Fatigue, Pyrexia, SARS-CoV-2 test, Vaccination site pain
Clinical narrative: Sore arm; Temp 102.8 to 104.1; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Sore arm), PYREXIA (Temp 102.8 to 104.1) and FATIGUE (Fatigue) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Apr-2021, the patient experienced PYREXIA (Temp 102.8 to 104.1) and FATIGUE (Fatigue). On an unknown date, the patient experienced VACCINATION SITE PAIN (Sore arm). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency and PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE PAIN (Sore arm), PYREXIA (Temp 102.8 to 104.1) and FATIGUE (Fatigue) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 02-Apr-2021, Body temperature: 102.8 to 104.1 (High) 102.8 to 104.1. On 02-Apr-2021, SARS-CoV-2 test:. On 05-Apr-2021, Body temperature: 101.8 (High) 101.8. On an unknown date, SARS-CoV-2 test: negative (Negative) Two COVID tests that came back negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 26-Jun-2021: Follow up received on 26-JUN-2021 - No new information
Age: 19.0
Sex: M
Vaccine: COVID19
Symptoms: Chest discomfort, Dyspnoea, Fatigue, Nausea, Vaccination site pain
Clinical narrative: pressure on his chest; trouble breathing; covid arm; nausea; fatigue; severe and very painful; This spontaneous case was reported by a consumer and describes the occurrence of CHEST DISCOMFORT (pressure on his chest), DYSPNOEA (trouble breathing), VACCINATION SITE REACTION (covid arm), NAUSEA (nausea) and FATIGUE (fatigue) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 018B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse effect.    On 03-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced CHEST DISCOMFORT (pressure on his chest), DYSPNOEA (trouble breathing), VACCINATION SITE REACTION (covid arm), NAUSEA (nausea), FATIGUE (fatigue) and VACCINATION SITE PAIN (severe and very painful). At the time of the report, CHEST DISCOMFORT (pressure on his chest), DYSPNOEA (trouble breathing), VACCINATION SITE REACTION (covid arm), NAUSEA (nausea), FATIGUE (fatigue) and VACCINATION SITE PAIN (severe and very painful) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 19.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site reaction
Clinical narrative: pressure on his chest; trouble breathing; covid arm; nausea; fatigue; severe and very painful; This spontaneous case was reported by a consumer and describes the occurrence of CHEST DISCOMFORT (pressure on his chest), DYSPNOEA (trouble breathing), VACCINATION SITE REACTION (covid arm), NAUSEA (nausea) and FATIGUE (fatigue) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 018B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse effect.    On 03-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced CHEST DISCOMFORT (pressure on his chest), DYSPNOEA (trouble breathing), VACCINATION SITE REACTION (covid arm), NAUSEA (nausea), FATIGUE (fatigue) and VACCINATION SITE PAIN (severe and very painful). At the time of the report, CHEST DISCOMFORT (pressure on his chest), DYSPNOEA (trouble breathing), VACCINATION SITE REACTION (covid arm), NAUSEA (nausea), FATIGUE (fatigue) and VACCINATION SITE PAIN (severe and very painful) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dyspepsia, Fatigue, Headache, Hypersomnia
Clinical narrative: Slept for 19 hours; Heartburn; headache; muscle ache; Extreme fatigue; Nausea; chills; This spontaneous case was reported by a consumer and describes the occurrence of HYPERSOMNIA (Slept for 19 hours), DYSPEPSIA (Heartburn), HEADACHE (headache), MYALGIA (muscle ache) and FATIGUE (Extreme fatigue) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 021B21A and 032M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No medical history reported).   On 07-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 31-Mar-2021, the patient experienced HYPERSOMNIA (Slept for 19 hours), DYSPEPSIA (Heartburn), HEADACHE (headache), MYALGIA (muscle ache), FATIGUE (Extreme fatigue), NAUSEA (Nausea) and CHILLS (chills). On 01-Apr-2021, HYPERSOMNIA (Slept for 19 hours), DYSPEPSIA (Heartburn), HEADACHE (headache), MYALGIA (muscle ache), FATIGUE (Extreme fatigue), NAUSEA (Nausea) and CHILLS (chills) had resolved.            No concomitant medication reported  Treatment using  ibuprofen 400mg was reported
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Nausea
Clinical narrative: Slept for 19 hours; Heartburn; headache; muscle ache; Extreme fatigue; Nausea; chills; This spontaneous case was reported by a consumer and describes the occurrence of HYPERSOMNIA (Slept for 19 hours), DYSPEPSIA (Heartburn), HEADACHE (headache), MYALGIA (muscle ache) and FATIGUE (Extreme fatigue) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 021B21A and 032M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No medical history reported).   On 07-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 31-Mar-2021, the patient experienced HYPERSOMNIA (Slept for 19 hours), DYSPEPSIA (Heartburn), HEADACHE (headache), MYALGIA (muscle ache), FATIGUE (Extreme fatigue), NAUSEA (Nausea) and CHILLS (chills). On 01-Apr-2021, HYPERSOMNIA (Slept for 19 hours), DYSPEPSIA (Heartburn), HEADACHE (headache), MYALGIA (muscle ache), FATIGUE (Extreme fatigue), NAUSEA (Nausea) and CHILLS (chills) had resolved.            No concomitant medication reported  Treatment using  ibuprofen 400mg was reported
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Feeling abnormal, Herpes zoster, Pelvic pain, Rash vesicular
Clinical narrative: Feels like "living in hell"; Shingles on stomach and Pelvic area/ Diagnosed with shingles; Red blistery rash on stomach and pelvic area; Stomach pain; Pelvic pain; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN UPPER (Stomach pain), PELVIC PAIN (Pelvic pain), HERPES ZOSTER (Shingles on stomach and Pelvic area/ Diagnosed with shingles), RASH VESICULAR (Red blistery rash on stomach and pelvic area) and FEELING ABNORMAL (Feels like "living in hell") in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047A21A) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy (Statins), Food allergy (strawberry's), Drug allergy (Aspirin), Drug allergy (Erythromycin), Drug allergy (Codeine), Food allergy (crabs), Food allergy (lobster) and Allergy (latex). Concomitant products included QUINAPRIL HYDROCHLORIDE (ACCUPRIL), AMLODIPINE, CLONAZEPAM, LORATADINE (CLARITIN [LORATADINE]), PREDNISONE, FLUTICASONE PROPIONATE, TRAMADOL, FISH OIL, COLECALCIFEROL (VITAMIN D [COLECALCIFEROL]) and DEXTRAN (TEARS NATURAL) for an unknown indication.    On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Apr-2021, the patient experienced ABDOMINAL PAIN UPPER (Stomach pain) and PELVIC PAIN (Pelvic pain). On 02-Apr-2021, the patient experienced HERPES ZOSTER (Shingles on stomach and Pelvic area/ Diagnosed with shingles) and RASH VESICULAR (Red blistery rash on stomach and pelvic area). On 05-Apr-2021, the patient experienced FEELING ABNORMAL (Feels like "living in hell"). The patient was treated with VALACICLOVIR HYDROCHLORIDE (VALACYCLOVIR HCL) ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, ABDOMINAL PAIN UPPER (Stomach pain), PELVIC PAIN (Pelvic pain), HERPES ZOSTER (Shingles on stomach and Pelvic area/ Diagnosed with shingles), RASH VESICULAR (Red blistery rash on stomach and pelvic area) and FEELING ABNORMAL (Feels like "living in hell") was resolving. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       On 16Mar2021 patient Received 1st Moderna Vaccination. Left arm(dominant) 01Apr2021 Developed stomach pain, pelvic pain 02Apr2021 Developed Shingles in areas of previous pain. Shingles are a red blistery rash. Went to MD. Diagnosed with Shingles. Treatment Valacyclovir. 03-05Apr2021 Described as feeling like living "in hell." 06Apr2021 Symptoms are resolving. Allergy's: Too long to list. Many medications: Statins, Aspirin, Erythromycin, Codeine, strawberry's, crabs, lobster, latex   Most recent FOLLOW-UP information incorporated above includes: On 27-May-2021: Follow-up received on 27-MAY-2021 and does not contain any new information. On 19-Jul-2021: Significant FU-AE details updated
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Fatigue, Maternal exposure during breast feeding, Temperature difference of extremities, Vaccination site swelling
Clinical narrative: temperature; fatigue; soreness; Exposure during breast feeding; Redness; This spontaneous case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING BREAST FEEDING (breast feeding), VACCINATION SITE SWELLING (soreness), ERYTHEMA (Redness), TEMPERATURE DIFFERENCE OF EXTREMITIES (temperature) and FATIGUE (fatigue) in a 35-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 020B21A) for an unknown indication.     The patient's past medical history included No adverse event. Concurrent medical conditions included No adverse event and No adverse event.    On 29-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Apr-2021, the patient experienced MATERNAL EXPOSURE DURING BREAST FEEDING (breast feeding), VACCINATION SITE SWELLING (soreness) and ERYTHEMA (Redness). On an unknown date, the patient experienced TEMPERATURE DIFFERENCE OF EXTREMITIES (temperature) and FATIGUE (fatigue). At the time of the report, MATERNAL EXPOSURE DURING BREAST FEEDING (breast feeding), VACCINATION SITE SWELLING (soreness), ERYTHEMA (Redness), TEMPERATURE DIFFERENCE OF EXTREMITIES (temperature) and FATIGUE (fatigue) outcome was unknown.            Treatment information were not provided.   This case was linked to MOD21-070697, US-MODERNATX, INC.-MOD-2021-068350 (E2B Linked Report).   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 06-Apr-2021: No specific follow-up information recorded.; Sender's Comments:  MOD21-070697: US-MODERNATX, INC.-MOD-2021-068350:CROSS LINKED WITH MOTHER'S CASE
Sex: F
Vaccine: COVID19
Symptoms: Maternal exposure during pregnancy, Pregnancy test
Clinical narrative: Pregnant; This spontaneous prospective pregnancy case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Pregnant) in a female patient of an unknown age (gravida 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025b21a) for COVID-19 vaccination.     Concurrent medical conditions included Allergy (mango, pineapple, strawberries, nuts), Asthma, Anxiety, Depression and Migraine. Concomitant products included ESCITALOPRAM OXALATE (LEXAPRO), MAGNESIUM, COLECALCIFEROL (VIT D3) and ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) for an unknown indication.    On 03-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 02-Sep-2020 and the estimated date of delivery was 24-Jun-2021. On 03-Apr-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Pregnant). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  thirtieth week of the pregnancy.  On 03-Apr-2021, MATERNAL EXPOSURE DURING PREGNANCY (Pregnant) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Pregnancy test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Other relevant concomitant medications included, stool softner medicines were reported.  Treatment information was not provided.   This case was linked to MOD-2021-240807 (Patient Link).
Age: 26.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Dizziness, Dyspnoea, Headache, Heart rate irregular
Clinical narrative: dizziness; feeling very lethargic; very short of breath; Heart beat is erratic; headaches; chills; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizziness), LETHARGY (feeling very lethargic), DYSPNOEA (very short of breath), HEART RATE IRREGULAR (Heart beat is erratic) and HEADACHE (headaches) in a 26-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027N21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 05-Apr-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On 06-Apr-2021, the patient experienced DIZZINESS (dizziness), LETHARGY (feeling very lethargic), DYSPNOEA (very short of breath), HEART RATE IRREGULAR (Heart beat is erratic), HEADACHE (headaches) and CHILLS (chills). At the time of the report, DIZZINESS (dizziness), LETHARGY (feeling very lethargic), DYSPNOEA (very short of breath), HEART RATE IRREGULAR (Heart beat is erratic), HEADACHE (headaches) and CHILLS (chills) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       no concomitant medications reported. no treatment details reported.
Age: 26.0
Sex: M
Vaccine: COVID19
Symptoms: Lethargy
Clinical narrative: dizziness; feeling very lethargic; very short of breath; Heart beat is erratic; headaches; chills; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizziness), LETHARGY (feeling very lethargic), DYSPNOEA (very short of breath), HEART RATE IRREGULAR (Heart beat is erratic) and HEADACHE (headaches) in a 26-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027N21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 05-Apr-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On 06-Apr-2021, the patient experienced DIZZINESS (dizziness), LETHARGY (feeling very lethargic), DYSPNOEA (very short of breath), HEART RATE IRREGULAR (Heart beat is erratic), HEADACHE (headaches) and CHILLS (chills). At the time of the report, DIZZINESS (dizziness), LETHARGY (feeling very lethargic), DYSPNOEA (very short of breath), HEART RATE IRREGULAR (Heart beat is erratic), HEADACHE (headaches) and CHILLS (chills) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       no concomitant medications reported. no treatment details reported.
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia
Clinical narrative: her elbow started hurting\ joint pain; extreme joint pain; her ankles started hurting; her wrists started hurting; other joint pain during the third week and they are lingering; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (her elbow started hurting\ joint pain), ARTHRALGIA (extreme joint pain), ARTHRALGIA (her ankles started hurting), ARTHRALGIA (her wrists started hurting) and ARTHRALGIA (other joint pain during the third week and they are lingering) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ARTHRALGIA (her elbow started hurting\ joint pain), ARTHRALGIA (extreme joint pain), ARTHRALGIA (her ankles started hurting), ARTHRALGIA (her wrists started hurting) and ARTHRALGIA (other joint pain during the third week and they are lingering). At the time of the report, ARTHRALGIA (her elbow started hurting\ joint pain), ARTHRALGIA (extreme joint pain), ARTHRALGIA (her ankles started hurting), ARTHRALGIA (her wrists started hurting) and ARTHRALGIA (other joint pain during the third week and they are lingering) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       no concomitant medications reported. no treatment details reported.
Sex: F
Vaccine: COVID19
Symptoms: Exposure during pregnancy
Clinical narrative: Vaccine exposure during pregnancy; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On 05-Apr-2021, the patient experienced EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy). On 05-Apr-2021, EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) had resolved.            Action taken with mRNA-1273 in response to the events was not applicable. Patient calling after receiving the second dose of the Moderna Covid 19 vaccine on 5Apr2021. She states that she just found out she was pregnant.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Chills, Eructation, Hyperhidrosis, Nausea
Clinical narrative: nausea; chills; in the morning sweating; in the morning some frequent belching; in the morning stomach ache; This spontaneous case was reported by a nurse and describes the occurrence of HYPERHIDROSIS (in the morning sweating), ERUCTATION (in the morning some frequent belching), ABDOMINAL PAIN UPPER (in the morning stomach ache), NAUSEA (nausea) and CHILLS (chills) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026AZ1A and 001A21A) for COVID-19 vaccination.     The patient's past medical history included H.pylori gastrointestinal disease (7 years ago).   On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-Apr-2021, the patient experienced HYPERHIDROSIS (in the morning sweating), ERUCTATION (in the morning some frequent belching) and CHILLS (chills). 04-Apr-2021, the patient experienced ABDOMINAL PAIN UPPER (in the morning stomach ache). On an unknown date, the patient experienced NAUSEA (nausea). The patient was treated with CALCIUM CARBONATE (TUMS [CALCIUM CARBONATE]) at an unspecified dose and frequency. At the time of the report, HYPERHIDROSIS (in the morning sweating), ERUCTATION (in the morning some frequent belching), ABDOMINAL PAIN UPPER (in the morning stomach ache) and NAUSEA (nausea) had resolved and CHILLS (chills) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter. Additional treatment included ginger ale.   Most recent FOLLOW-UP information incorporated above includes: On 17-May-2021: Follow-up information received on 17-MAY-2021 contains significant information - events resolved